lower wall stress if they could be dissociated from deleterious collateral effects, the molecular dissection of hypertrophy signaling pathways has long been a goal. A central pathway transducing reactive hypertrophy signaling has been linked to the heterotrimeric G protein Gαq transgenic (Gq), which is stimulated by prohypertrophic hormones such as angiotensin II, endothelin, and α-adrenergic agonists. Accordingly, mice with cardiomyocyte-specific overexpression of the catalytically active α subunit of Gq develop marked cardiac hypertrophy that recapitulates hypertrophy development and subsequent decompensation. 5 Conversely, Gαq/Gα 11 knockout mice are unable to develop hypertrophy in response to pressure overload. 6 Gq signaling has been linked to increases in intracellular calcium, suggesting the Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) as a potential downstream signaling effector of Gq-mediated hypertrophy and heart failure. 7 Indeed, myocardial overexpression of the predominant cardiac CaMKII isoform (CaMKIIδ C ), like overexpression of Gαq, is sufficient to induce hypertrophy that transitions to severe cardiac dysfunction. 8 Conversely, inhibition or genetic ablation of CaMKIIδ prevents cardiac dysfunction after transverse aortic constriction (TAC), myocardial infarction, or ischemia/reperfusion. [9] [10] [11] [12] The ability of CaMKII to phosphorylate key calcium handling proteins was initially considered to be the major driver underlying its involvement in cardiac disease, but normalization of CaMKIIinduced changes in sarcoplasmic reticulum calcium proved insufficient to prevent heart failure induced by CaMKIIδ overexpression. 13 Gq-induced cardiac decompensation has been associated with mitochondrial dysfunction and increased mitochondrial reactive oxygen species (ROS) generation. [14] [15] [16] Adverse effects of CaMKII have also been shown to be associated with altered mitochondrial calcium handling and oxidative phosphorylation. 13, 17, 18 These observations raise the possibility that CaMKIIδ might serve as the downstream mediator of the maladaptive mitochondrial effects of Gq signaling. Were this the case, combined manipulation of Gq and CaMKIIδ would shed light on the specific molecular mechanisms by which Gq stimulates and CaMKIIδ mediates hypertrophy decompensation. We demonstrate here that CaMKIIδ deletion attenuates the maladaptive cardiac effects of Gq, including mitochondrial dysfunction, by modulating the expression of nuclear-encoded mitochondrial genes. We suggest that CaMKIIδ-induced repression of uncoupling protein 3 (UCP3) is one of the drivers of mitochondrial dysfunction and decompensation to heart failure.
Methods
A more detailed description of the methods has been included as an Online Data Supplement.
Animal Models
The generation of Gαq-40 transgenic mice and CaMKIIδ knockout mice has been described previously. 5, 9 To study the role of CaMKIIδ in Gαq-induced heart failure, Gq mice were crossed into a CaMKIIδ knockout background, to yield wild type (WT), CaMKIIδ knockout (KO), Gq, and Gq mice in a CaMKIIδ knockout background (Gq/ KO). Studies involving pressure overload used the recently generated cardiac-specific CaMKIIδ knockout mice. 12 
RNA Sequencing
Left ventricular RNA was isolated from 4 mice from each group and processed for RNA sequencing studies as previously described.
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Mitochondrial Bioenergetics
Mouse heart mitochondria were isolated by differential centrifugation, and respiration was measured using a Seahorse XF24 analyzer as previously described.
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Biochemical and Histological Analysis
Tissue fractionation, RNA isolation, and Western blot analysis were performed as described previously. 9, 21 Cardiac mitochondrial protein carbonyl was measured using OxiSelect protein carbonyl ELISA kit (Cell Biolabs, San Diego, CA).
Neonatal Ventricular Cardiomyocyte Culture and Live Cell Imaging
Neonatal rat ventricular myocytes (NRVMs) were isolated, cultured, infected, and transfected as described previously.
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Statistical Analysis
All data are presented as mean±SEM. Comparisons between groups were performed using the Student t test, the Mann-Whitney U test, Kruskal-Wallis test, or 1-way ANOVA, followed by the Tukey post hoc test, where appropriate. A P value <0.05 was considered statistically significant.
Results
CaMKIIδ Deletion Does Not Affect Gαq-Induced Cardiac Hypertrophy
Cardiac hypertrophy and depressed contractile performance induced by Gαq overexpression have been thoroughly described. 5 Consistent with previous reports, gravimetric, echocardiographic, and histological analysis revealed significant increases in left ventricular mass and histological cardiomyocyte cross-sectional area in Gq mice compared with WT mice ( Figure 1A-1C) . We also observed activation of CaMKIIδ in the Gq compared with WT mouse heart, as indicated by increased CaMKII autophosphorylation and oxidation as well as by increased phosphorylation of phospholamban at threonine 17, a CaMKII-specific site (Online Figure I ). Genetic ablation of CaMKIIδ did not diminish Gqinduced cardiac hypertrophy as assessed by comparison of Gq and Gq/KO mice on multiple readouts ( Figure 1A-1C) . Likewise, hypertrophy of NRVMs induced by adenoviral expression of constitutively active Gαq (Ad-Q209L) and e30
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demonstrated by increased cardiomyocyte size and ANF (atrial natriuretic factor) immunostaining ( Figure 1D ) was unaffected by pharmacological blockade of CaMKII with KN93. Thus, the ability of Gq to elicit genetic and morphological changes characteristic of cardiomyocyte hypertrophy does not depend on CaMKII activation.
CaMKIIδ Deletion Prevents Functional Decompensation in Gq Mice
Compared with WT littermates, 8-week-old Gq mice had reduced fractional shortening ( Figure 2A ) and left ventricular systolic dilatation ( Figure 2B ), decreased load-independent ventricular contractility and relaxation indices ( Figure 2C ), Figure  IIA) . Another determinant of functional decompensation, lung weight/body weight ratios, was also significantly increased in Gq mice ( Figure 2D ). All of these changes were ameliorated by deletion of CaMKIIδ (Figure 2A-2D ; Online Figure IIA ). Other characteristic heart failure-associated phenotypes of Gq mice, including cardiomyocyte apoptosis, fibrosis, and ventricular arrhythmias, were likewise improved by CaMKIIδ ablation (Online Figure IIB-IIE) . Thus, while structural Gq-stimulated cardiac hypertrophy was maintained in the face of CaMKIIδ deficiency (Figure 1) , abrogation of CaMKIIδ prevented the associated cardiac decompensation (Figure 2 ).
CaMKIIδ Deletion Attenuates Mitochondrial Dysfunction and Mitochondrial Oxidative Stress
The cardiomyopathy of pressure overload is mediated, in part, through disruption of the electron transport chain and increased mitochondrial oxidative stress. 4 To determine whether Gq signaling affects mitochondrial function in a CaMKII-dependent manner, we isolated mitochondria from the 4 mouse lines and measured their oxygen consumption rate drive ( Figure 3A ). Pyruvate-driven respiration was 40% lower in ventricular mitochondria isolated from Gq than in those isolated from WT mice ( Figure 3B ). This impairment was significantly reversed in mitochondria isolated from the Gq/KO mice ( Figure 3B) . A similar improvement in mitochondrial respiration in Gq/KO mice was observed with the other complex I substrates palmitoylcarnitine and glutamate, whereas respiration on the complex II substrate succinate was not different in Gq/KO versus Gq mice (data not shown). State 4 respiration (oligomycin) and respiratory control ratios were comparable between all 4 mouse lines. Together these data indicate that the effect of CaMKIIδ on complex I contribute to impaired mitochondrial respiration induced downstream of Gq.
To more directly link Gq and CaMKII signaling to mitochondrial function, we examined changes in mitochondrial oxidative stress. ROS were assessed by dihydroethidium fluorescence staining in ventricular sections from hearts of all 4 genotypes. Dihydroethidium fluorescence was markedly increased in Gq mice and was reduced ≈50% by concomitant CaMKIIδ deletion ( Figure 3C ). To confirm data obtained using dihydroethidium fluorescence changes, we evaluated oxidative damage to mitochondrial proteins by quantifying protein carbonyls in isolated mitochondria. In line with previous observations, 15 mitochondrial protein carbonyls were increased 3-fold in the Gq mouse heart ( Figure 3D ). Remarkably, this increase was significantly attenuated in Gq/ KO mice ( Figure 3D ).
CaMKIIδ Activation Induces Mitochondrial Oxidative Stress in Cardiomyocytes
To corroborate and add mechanistic insight to these in vivo findings, NRVMs were infected with an adenovirus expressing Ad-Q209L, with or without the addition of the CaMKII inhibitor KN93 or of an adenovirus expressing catalytically dead CaMKIIδ. Ad-Q209L infection resulted in a 6-fold increase in mitochondrial ROS accumulation assessed by MitoSox fluorescence. The Gq-mediated increase in MitoSox fluorescence was reduced by >50% in cells treated with KN93 ( Figure 4A ) or coinfected with adenovirus expressing catalytically dead CaMKIIδ (Online Figure IIIA) . Conversely, expression of a constitutively activated CaMKIIδc adenovirus (Ad-CaMKIIδ) significantly increased the MitoSox signal in NRVMs (Online Figure IIIB) .
CaMKIIδ and ROS Generation Mediate Gαq-Induced Mitochondria-Mediated Cell Death
Expression of Q209L also led to marked increases in mitochondrial depolarization (assessed using tetramethylrhodamine ethyl ester) and apoptosis (measured by DNA fragmentation), which were prevented by inhibition of CaMKIIδ with KN93 or expression of adenovirus expressing catalytically dead CaMKIIδ (Online Figures IIIC, IIID , and IVA). We used N-acetylcysteine as an ROS-scavenger to test the role of ROS in Ad-Q209L-induced cell death. Treatment with N-acetylcysteine decreased Q209L-induced cell death by ≈60% and did not further reduce cell death in the presence of KN93 ( Figure 4B ). The observation that N-acetylcysteine 
CaMKIIδ Deletion Prevents Mitochondrial Gene Reprogramming in Gαq-Induced Heart Failure
A plethora of transcriptional responses accompany Gq expression and development of decompensation in the mouse heart, including changes in genes that affect mitochondrial function. 19 We applied deep RNA sequencing to discover genes that were differentially regulated in the hearts of Gq mice compared with Gq/KO mice. Of the 335 genes that differed in the hearts of 4-week-old Gq versus WT mice, one third (118 genes) were normalized by CaMKIIδ deletion ( Figure 5A ). Gene ontology analysis further revealed that 17 genes encoding mitochondrial proteins (41% of the mitochondrial genes that were differentially regulated in Gq versus WT mice) were normalized in Gq/KO mice ( Figure 5B ). The 17 mitochondrial genes normalized by CaMKIIδ deletion (bolded in Figure 5C ) mediate processes such as mitochondrial substrate transport and oxidation, electron transport chain function, and ATP synthesis. Many of these genes, including cytochrome c (CYC1) and NDU subunits (NDUFAB1 and NDUF58), are components of the electron transport chain and changes in these genes may at least partially explain the alterations in mitochondrial respiration demonstrated in Figure 3 .
Gq and CaMKIIδ Regulate UCP3 and Peroxisome Proliferator-Activated Receptor α
One of the mitochondrial gene transcripts found to be markedly downregulated in Gq mice and restored in Gq/KO mice ( Figure 5C) observed through RNA sequencing was confirmed by changes in UCP3 protein expression in mitochondria isolated from Gq and Gq/KO mice ( Figure 6A ). To further explore the mechanism and significance of Gq signaling to UCP3, we examined the regulation of UCP3 in NRVMs infected with Ad-Q209L. UCP3 mRNA and protein expression were significantly decreased in cells expressing Q209L, and this was prevented by KN93 ( Figure 6B and 6C) , confirming a role for CaMKII in the regulation of UCP3 expression. Peroxisome proliferator-activated receptor α (PPAR-α) has been suggested to regulate the expression of UCP3. [22] [23] [24] We analyzed the 17 mitochondrial genes normalized by CaMKIIδ deletion for transcription factor binding site enrichment and conservation in their 5-kb proximal promoters as previously described. 25 This analysis showed significant enrichment (P<0.0001) for PPAR-α binding sites. Moreover, analysis of the RNA sequencing data described above demonstrated that PPAR-α mRNA levels were reduced by one third in Gq mice compared with WT mice (P=0.00032) but not in Gq/KO versus WT mice. Western blot analysis revealed concomitant changes in PPAR-α protein expression; PPAR-α was decreased in the Gq, and this was normalized by CaMKIIδ deletion ( Figure 6D ). Expression of Q209L in NRVMs also effectively decreased PPAR-α mRNA through CaMKII signaling (Figure 6E ), consistent with a direct effect of Gq activation on PPAR-α expression. Furthermore, the expression of PPAR-α-dependent genes, such as carnitine palmitoyltransferase 1B (CPT-1b) and pyruvate dehydrogenase To demonstrate a functional relationship between PPAR-α and UCP3 expression, we downregulated PPAR-α with small interfering RNA (siRNA). Greater than 85% downregulation of PPAR-α protein expression was achieved by siRNA treatment (data not shown). Knockdown of PPAR-α significantly decreased basal levels of UCP3 expression ( Figure 6F ), directly demonstrating that UCP3 expression is regulated by PPAR-α. Additionally, UCP3 levels were not further diminished by Ad-Q209L or Ad-CaMKIIδ when PPAR-α was downregulated ( Figure 6F ). Together these findings suggest that CaMKII downregulates UCP3 expression through inhibition of PPAR-α and that this occurs downstream of Gq signaling.
UCP3 Contributes to ROS Production and Cell Death
We carried out loss-and gain-of-function experiments using UCP3 siRNA and adenovirus to demonstrate a causal relationship between decreased UCP3 expression and Gαq/ CaMKII-mediated mitochondrial ROS generation and cell death. Treatment with UCP3 siRNA reduced UCP3 expression in NRVMs by 80% (Online Figure VIIA) . The ability of KN93 to inhibit Q209L-induced mitochondrial ROS accumulation ( Figure 7A ) and cell death ( Figure 7B ) were both abrogated when UCP3 was depleted. The protective effect of adenovirus expressing catalytically dead CaMKIIδ on cell death induced by Q209L was also blocked (Online Figure IVB) . To further establish the importance of UCP3 downregulation in Gαq-and CaMKII-mediated mitochondrial ROS generation and cell death, we generated an adenovirus expressing UCP3 (Ad-UCP3). Infection with Ad-UCP3 resulted in a 2.5-fold increase in expression of UCP3 and also normalized UCP3 expression in cells coinfected with Ad-Q209L (Online Figure VIIB) . Importantly, the ability of Ad-Q209L and Ad-CaMKIIδ to induce mitochondrial ROS accumulation ( Figure 7C ) and cell death ( Figure 7D ) was significantly attenuated by coexpression of UCP3. In the above experiments, an adenovirus expressing CaMKIIδc was used. To assess whether the mitochondrial reprogramming was CaMKIIδ subtype specific, we compared the response to adenoviral expression of the 2 major cardiac CaMKIIδ isoforms, CaMKIIδc and CaMKIIδb. CaMKIIδ-mediated downregulation of UCP3, PPAR-α, and other PPAR-α-dependent genes was observed after infection with constitutively activated CaMKIIδc, but these genes remained unchanged after infection with constitutively activated CaMKIIδb (Online Figures VE, VF, and VI) .
CaMKIIδ Deletion Prevents Mitochondrial Stress in Pressure Overload-Induced Heart Failure
We previously demonstrated that CaMKIIδ is required for the transition from hypertrophy to heart failure following TACinduced pressure overload. 9 To prove that the CaMKII signaling pathway responsible for decompensation to failure was cardiomyocyte autonomous, we generated cardiac-specific CaMKIIδ KO mice. 12 We examined their response to pressure overload induced by TAC and determined that deletion of CaMKIIδ did not prevent TAC-induced increases in hypertrophy ( Figure 8A ). Despite development of hypertrophy, the loss of CaMKIIδ in cardiomyocytes significantly attenuated the development of ventricular dilation and the decrease in fractional shortening ( Figure 8B and 8C). In addition, mitochondrial oxidative stress assessed by protein carbonylation was increased after TAC through a CaMKIIδ-dependent process ( Figure 8D ). Remarkably, as observed for the Gq mice, pressure overload resulted in decreases in PPAR-α and UCP3 expression, and these changes were attenuated in the absence of CaMKIIδ ( Figure 8E) . Thus, the effect of CaMKIIδ on mitochondrial oxidative stress and heart failure development extends beyond the Gq model of cardiomyopathy to also include the response to pressure overload.
Discussion
Clinical therapeutics has aimed at preventing or reversing hypertrophy in patients with heart disease because conventional wisdom holds that reactive hypertrophy is maladaptive and perhaps dispensable for functional compensation to hemodynamic overload. 26 Hypertrophic growth is, however, an evolutionarily conserved cardiac response to reduce ventricular wall stress in pressure overloaded or dilated ventricles. 1 The problem is that this reactive hypertrophy ultimately progresses into a maladaptive cardiomyopathy with decreased survival. It would therefore seem most therapeutically beneficial to retain the physically advantageous features of cardiac hypertrophy that reduce wall stress, while preventing its subsequent decompensation. Our previous work suggests that CaMKIIδ, while dispensable for hypertrophic growth, plays a key role in the transition from hypertrophy to heart failure. 9 How this occurs, and whether CaMKIIδ activation is an essential component Figure 8 . Ca 2+ /calmodulin-dependent protein kinase II δ (CaMKIIδ) deletion prevents mitochondrial oxidative stress in pressure overload-induced heart failure. Cardiomyocyte-specific CaMKIIδ knockout mice (KO) or their littermate controls (Ctrl) were subjected to transverse aortic constriction (TAC). A, Heart weight/body weight ratio (HW/BW, n=6-9) 2 weeks after TAC. B and C, Changes in echocardiographic indices of left ventricular (LV) function and LV dilatation after TAC. Shown are left ventricular internal systolic diameter (LVIDs, B) and fractional shortening (C; n=8). D, Carbonylation of mitochondrial proteins in wild type (WT) and global KO mice as measured by ELISA of cardiac mitochondrial homogenates 6 weeks after TAC (n=5-8 per group). E, Peroxisome proliferator-activated receptor α (PPAR-α) and uncoupling protein 3 (UCP3) protein expression normalized for α-actinin measured in lysates from mouse ventricle 6 weeks after TAC. All values are expressed as mean±SEM. #P<0.05 vs Ctrl-sham or WT-sham; *P<0.05 vs Ctrl-TAC or WT-TAC.
by guest on April 3, 2018 http://circres.ahajournals.org/ Downloaded from e37 of pathological hypertrophy downstream of Gq signaling, is not known. Here, we used combined genetic manipulation of Gq and CaMKIIδ to dissociate growth-promoting and heart failure-inducing hypertrophy signals, in effect beneficially remodeling reactive hypertrophy. In so doing, we uncovered mitochondrial reprogramming as a key mediator of CaMKIIδ-induced hypertrophy decompensation, further emphasizing the potential for CaMKII as a therapeutic target.
Mitochondrial Reprogramming Through CaMKIIδ as a Central Driver in Hypertrophy Decompensation
Mitochondrial reprogramming occurs during heart failure development and is characterized by a shift from fatty acid to glucose utilization, reduced ATP availability, and increased mitochondrial oxidative stress. 27 The relevance of mitochondrial reprogramming is underscored by the ability of mitochondrial-targeted antioxidants to prevent pathological hypertrophy and cardiac aging. 15, [28] [29] [30] CaMKII is now known to be activated not only by calcium but also by oxidation. 31 Although it is clear that ROS generation and concomitant CaMKII oxidation contribute to the pathophysiology of heart disease, [31] [32] [33] [34] the possibility that this maladaptive cascade is further accentuated by reciprocal effects of CaMKII on ROS production has not been previously considered. In the present study, we provide evidence that CaMKIIδ induces altered mitochondrial gene expression associated with mitochondrial dysfunction, mitochondrial oxidative stress, and ROS-driven cell death. First, we show that CaMKIIδ mediates mitochondrial reprogramming downstream of Gq signaling. Second, we demonstrate that CaMKIIδ-induced mitochondrial reprogramming is associated with impaired respiration and increased mitochondrial oxidative stress. Third, we demonstrate that increased oxidative stress induced by CaMKIIδ contributes to cardiomyocyte cell death and cardiomyopathy. Globally, these findings implicate CaMKIIδ as a central mediator of the mitochondrial reprogramming and cardiomyocyte loss associated with heart failure development.
Critical Role for UCP3 in CaMKIIδ-Induced Mitochondrial ROS in the Heart
When activated, 23, 35 uncoupling proteins can induce a proton leak by dissipating the proton motive force across the inner mitochondrial membrane, thereby reducing ROS generation at the cost of a reduction in coupling efficiency. 36 UCP3 is a major UCP isoform in the heart, and it seems to be critical for the cardiac response to multiple stresses. [36] [37] [38] [39] [40] [41] [42] Downregulation of UCP3 has been associated with increased cardiac ROS levels in a model of doxorubicin-induced heart failure. 37 The antioxidant effects of hexokinase-II and stanniocalcin-1 in cardiomyocytes have been suggested to involve UCP3. 38, 39 Studies using UCP3 knockout mice demonstrate increased angiotensin-induced cardiac ROS levels and greater susceptibility to oxidative stress. 39, 42 Furthermore, UCP3 knockout mice show impaired myocardial energetics and larger infarcts in response to cardiac ischemia/ reperfusion. 41 These findings are consistent with and extended by our observation that Gq-induced mitochondrial ROS generation is mediated, at least in part, through transcriptional repression of UCP3. Here, we further demonstrate that CaMKII contributes to UCP3 downregulation in response to Gq and that this downregulation is functionally important in mediating Gq and CaMKII-induced ROS accumulation and cell death. Our findings suggest that activation of CaMKII, which occurs in response to multiple agonists and stressors, is a nodal point for regulation of mitochondrial ROS generation which in turn sustains a maladaptive feed forward cycle in which ROS generation further activates CaMKII signaling. 31 There is a broad precedent for transcriptional regulation of UCP3 by pharmacological interventions and physiological stress. 36 The role of CaMKII in transcriptional regulation has also been well documented. 7 Here, we demonstrate CaMKIIdependent decreases in expression of both UCP3 and the transcription factor PPAR-α in hearts of Gq mice and in NRVMs expressing activated Gq or CaMKIIδ. siRNA-mediated knockdown of PPAR-α reduced UCP3 expression, and no further effects of Gq or CaMKII on UCP3 expression were observed in the absence of PPAR-α, supporting a role for PPAR-α in transcriptional control of UCP3. We also report decreases in both UCP3 and PPAR-α following pressure overload, which are rescued by CaMKIIδ deletion. PPAR-α has been shown to be reduced in experimental models of heart failure and PPAR-α agonists shown to preserve cardiac function. 22, 36, 43, 44 The observation that the CaMKII-regulated mitochondrial genes are significantly enriched for PPAR-α-binding sites suggests a mechanism by which CaMKII activation would induce mitochondrial reprogramming and associated decompensation to heart failure. How CaMKII downregulates PPAR-α and subsequently UCP3 remains to be determined. We used pharmacological inhibitors to test effects of both class I and class II histone deacylases on this process in NRVMs but failed to observe any block of CaMKIIδc-mediated PPAR-α or UCP3 downregulation. Another possible mechanism for gene repression by CaMKII could be through effects on microRNAs, a topic that is of considerable interest but clearly beyond the scope of the present study.
Clinical Implications
Using cellular and murine models of pathological hypertrophy induced by sustained Gq-signaling, we show that deletion of the predominant cardiac isoform (CaMKIIδ) does not block development of hypertrophy but prevents the transition from compensatory cardiac hypertrophy into dilated cardiomyopathy. Our study therefore shows that CaMKIIδ is dispensable for Gq-induced hypertrophy but critical for the subsequent transition from hypertrophy to heart failure. Importantly, similar observations are made when pressure overload rather than Gq is used as a stressor. CaMKII is activated downstream of multiple neurohumoral agonists, including β-adrenergic agonists, angiotensin II, and aldosterone, and plays a crucial role in their pathophysiological effects in the heart. 7, 45, 46 Accordingly, pharmacological inhibitors of CaMKII may offer novel therapeutic opportunities for specifically blocking the maladaptive effects of hypertrophy induced by multiple insults.
Limitations
CaMKIIδ can localize to mitochondria, and a recent study determined that mitochondrial-localized CaMKII plays a central role in cardiac ischemia/reperfusion injury. 18 Our study was focused on CaMKII-induced changes in mitochondrial gene transcription, but we cannot exclude the possibility that salutary effects of deleting CaMKIIδ on mitochondrial function are also mediated, in part, by changes in the activity of CaMKII in mitochondria. In addition, a recent study suggested that CaMKII stimulates NADPH (nicotinamide adenine dinucleotide phosphate) oxidase-mediated ROS production, suggesting that CaMKII could also exert detrimental effects by increasing ROS levels through extramitochondrial mechanisms. 47 The observation that state 4 respiration and respiratory control ratios were comparable between the groups might appear inconsistent with there being a major role for UCP3 downregulation in the mitotoxicity induced by CaMKII. However, our assay conditions were not optimized for the purpose of detecting subtle differences in coupling, thus such changes would not have been observed under our assay conditions. Despite these possible limitations, our study provides compelling evidence for a role of CaMKII and UCP3 in controlling mitochondrial oxidative stress in the heart.
Conclusions
Mitochondrial reprogramming by CaMKIIδ contributes to the maladaptive transition from Gq-mediated hypertrophy to cardiomyopathy. #"
